The ABPI will be
celebrating Biology Week 2017 from the 9 - 13 October. We'll be focusing on the innovation in our industry and how our ABPI Schools resources are driven by the scientific advances made by our members.
The ABPI represents innovative biopharmaceutical companies in the UK striving to research and develop the next generation of medicines for hard-to-treat diseases. These pioneers are helping us understand the mechanisms behind disease and the intricacies of human biology now more than ever before. Research projects in laboratories across the world are being transformed from the theoretical to the possible, supported by the pharmaceutical industry.
Biology Week is all about showcasing the amazing work done in the biosciences and I can think of no better example than the ABPI Schools website for highlighting how the leading edge of research is being made available to students and teachers. Our resources are curriculum-linked, but that doesn't mean we aren't using the most up-to-date science and research to educate and inspire the next generation of scientists.
Just as last weeks' Nobel prize announcements help motivate a new generation of young people to explore where a future in science can take them, so to does the inspiring work of our members: captured and made available through the ABPI Schools website. Explore our Biology Week hub to find out more about our resources or visit our award-winning website to check them out now.
Andrew Croydon, ABPI
The ABPI website for schools and colleges is highly valued by teachers. It provides teachers and students with high quality, free, curriculum related, interactive resources containing animations and diagrams which can be downloaded. All our resources link science topics covered in school to the world outside and, particularly, to the treatment of disease.
Visit the website to explore the wide variety of science curriculum-linked subjects.
We'll be sharing the best of our members' content on Twitter @ABPI_UK. We've got over 60 full members: small, medium and large, all working to push back the frontiers of human understanding about disease and developing future medicines.
Ann Fullick: Education matters: how support from the pharmaceutical industry can help drive learning
Dr Rebecca Lumsden: Tackling the superbugs: this global fight needs global partners
Nicola Platt: The role of animal research in developing new medicines
Dr Jacintha Sivarajah: The future of research lies with today's young people
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies supplying more than 80 per cent of all branded medicines used by the NHS, and are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
Globally, our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.